Treatment failures and secondary resistance to antibiotics.: A growing concern in Helicobacter pylori therapy

被引：20

作者：

de Boer, WA

Borody, TJ

机构：

[1] Hosp Bernhoven, Dept Internal Med, NL-5340 BE Oss, Netherlands

[2] Ctr Digest Dis, Five Dock, Australia

来源：

关键词：

D O I：

10.1016/S1590-8658(00)80328-X

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：673 / 675

页数：3

共 31 条

[1] Borody TJ, 2000, HELICOBACTER PYLORI: BASIC MECHANISMS TO CLINICAL CURE 2000, P623
[2] Broutet N, 2000, GUT, V47, pA102
[3] Metronidazole resistance reduces efficacy of triple therapy and leads to secondary clarithromycin resistance
Buckley, MJM
Xia, HX
Hyde, DM
Keane, CT
OMorain, CA
[J]. DIGESTIVE DISEASES AND SCIENCES, 1997, 42 (10) : 2111 - 2115
[4] Calvet X, 2000, ALIMENT PHARM THER, V14, P603
[5] Canena JM, 1999, GASTROENTEROLOGY, V116, pA131
[6] Regular review -: Treatment of Helicobacter pylori infection
de Boer, WA
Tytgat, GNJ
[J]. BRITISH MEDICAL JOURNAL, 2000, 320 (7226) : 31 - 34
[7] De Boer WA, 2000, HELICOBACTER PYLORI: BASIC MECHANISMS TO CLINICAL CURE 2000, P609
[8] Gisbert JP, 2000, GUT, V47, pA104
[9] Goddard AF, 1997, GUT, V41, pA96
[10] Secondary resistance among 554 isolates of Helicobacter pylori after failure of therapy
Heep, M
Kist, M
Strobel, S
Beck, D
Lehn, N
[J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2000, 19 (07) : 538 - 541